Clinical Trial Update: TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers: R-baclofen Effects in Normal Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating TMS measures of plasticity and excitatory/inhibitory ratio as biomarkers and the effects of R-baclofen in healthy volunteers; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• R-baclofen (R-baclofen)

Snippet

Sponsor: Gonzalez-Heydrich, Joseph, M.D. | Conditions: Autism | Phase 1 | Status: TERMINATED